FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2922369568> ?p ?o ?g. }

• W2922369568 endingPage "749" @default.
• W2922369568 startingPage "736" @default.
• W2922369568 abstract "Talimogene laherparepvec, a herpes simplex virus type 1-based intralesional oncolytic immunotherapy, is approved in Europe for the treatment of adults with unresectable stage IIIB-IVM1a melanoma, with no bone, brain, lung or other visceral disease. It has direct oncolytic effects in injected lesions, leading to the release of tumour-derived antigens and systemic immune effects mediated by the induction of anti-tumour immunity, which is enhanced by the production of granulocyte macrophage colony-stimulating factor. Responses (which occur in >40% of stage IIIB-IVM1a patients) are often durable (>50% last ≥6 months) and occur in injected and uninjected lesions (in stage IIIB-IVM1c patients, 64%/34% of evaluable injected/uninjected non-visceral lesions, respectively, decreased in size by ≥50%). As with other immunotherapies, responses may be delayed or can arise after pseudoprogression. The pattern of treatment-emergent adverse events is distinct, being mostly grade 1/2, easy to manage, and rarely leading to treatment discontinuation. Systemic therapy represents the backbone of care for many metastatic melanoma patients. Nonetheless, the potential for durable locoregional control with a locally injected agent may make talimogene laherparepvec suitable for selected patients with stage IIIB/C disease, for whom surgery is not possible (e.g. with in-transit metastases, multiple melanoma lesions at different body sites, or those relapsing rapidly after repeated rounds of surgery) and slowly progressing disease. Here, we discuss which patients could be suitable for talimogene laherparepvec monotherapy based on the European indication, review the patterns/timing of response, and discuss the incidence/management of adverse events. Its potential use combined with immune checkpoint inhibitors is also discussed." @default.
• W2922369568 created "2019-03-22" @default.
• W2922369568 creator A5002992522 @default.
• W2922369568 creator A5015081105 @default.
• W2922369568 creator A5025478490 @default.
• W2922369568 creator A5029309849 @default.
• W2922369568 creator A5037399273 @default.
• W2922369568 creator A5038986027 @default.
• W2922369568 creator A5050063952 @default.
• W2922369568 creator A5089297467 @default.
• W2922369568 date "2018-11-01" @default.
• W2922369568 modified "2023-10-18" @default.
• W2922369568 title "Practical clinical guide on the use of talimogene laherparepvec monotherapy in patients with unresectable melanoma in Europe" @default.
• W2922369568 cites W1565001940 @default.
• W2922369568 cites W1965352121 @default.
• W2922369568 cites W1968095188 @default.
• W2922369568 cites W1994993231 @default.
• W2922369568 cites W2011513757 @default.
• W2922369568 cites W2019607817 @default.
• W2922369568 cites W2024346536 @default.
• W2922369568 cites W2031638224 @default.
• W2922369568 cites W2082150850 @default.
• W2922369568 cites W2086591619 @default.
• W2922369568 cites W2097995306 @default.
• W2922369568 cites W2099648846 @default.
• W2922369568 cites W2100158834 @default.
• W2922369568 cites W2108216382 @default.
• W2922369568 cites W2109274792 @default.
• W2922369568 cites W2114041298 @default.
• W2922369568 cites W2124262559 @default.
• W2922369568 cites W2152897456 @default.
• W2922369568 cites W2157370605 @default.
• W2922369568 cites W2165320653 @default.
• W2922369568 cites W2169131681 @default.
• W2922369568 cites W2196621737 @default.
• W2922369568 cites W2263896208 @default.
• W2922369568 cites W2268765157 @default.
• W2922369568 cites W2283630901 @default.
• W2922369568 cites W2286032567 @default.
• W2922369568 cites W2295382849 @default.
• W2922369568 cites W2339612083 @default.
• W2922369568 cites W2473956396 @default.
• W2922369568 cites W2494135329 @default.
• W2922369568 cites W2508710837 @default.
• W2922369568 cites W2516467363 @default.
• W2922369568 cites W2529373149 @default.
• W2922369568 cites W2547428353 @default.
• W2922369568 cites W2555619826 @default.
• W2922369568 cites W2558696481 @default.
• W2922369568 cites W2568822576 @default.
• W2922369568 cites W2589751944 @default.
• W2922369568 cites W2592144107 @default.
• W2922369568 cites W2626018034 @default.
• W2922369568 cites W2736194991 @default.
• W2922369568 cites W2741932379 @default.
• W2922369568 cites W2750781282 @default.
• W2922369568 cites W2751454205 @default.
• W2922369568 cites W2752210999 @default.
• W2922369568 cites W2752227448 @default.
• W2922369568 cites W2783905026 @default.
• W2922369568 cites W4211238487 @default.
• W2922369568 cites W4238123838 @default.
• W2922369568 cites W84369551 @default.
• W2922369568 doi "https://doi.org/10.1684/ejd.2018.3447" @default.
• W2922369568 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30698145" @default.
• W2922369568 hasPublicationYear "2018" @default.
• W2922369568 type Work @default.
• W2922369568 sameAs 2922369568 @default.
• W2922369568 citedByCount "5" @default.
• W2922369568 countsByYear W29223695682020 @default.
• W2922369568 countsByYear W29223695682021 @default.
• W2922369568 countsByYear W29223695682022 @default.
• W2922369568 countsByYear W29223695682023 @default.
• W2922369568 crossrefType "journal-article" @default.
• W2922369568 hasAuthorship W2922369568A5002992522 @default.
• W2922369568 hasAuthorship W2922369568A5015081105 @default.
• W2922369568 hasAuthorship W2922369568A5025478490 @default.
• W2922369568 hasAuthorship W2922369568A5029309849 @default.
• W2922369568 hasAuthorship W2922369568A5037399273 @default.
• W2922369568 hasAuthorship W2922369568A5038986027 @default.
• W2922369568 hasAuthorship W2922369568A5050063952 @default.
• W2922369568 hasAuthorship W2922369568A5089297467 @default.
• W2922369568 hasBestOaLocation W29223695681 @default.
• W2922369568 hasConcept C121608353 @default.
• W2922369568 hasConcept C126322002 @default.
• W2922369568 hasConcept C141071460 @default.
• W2922369568 hasConcept C143998085 @default.
• W2922369568 hasConcept C146357865 @default.
• W2922369568 hasConcept C151730666 @default.
• W2922369568 hasConcept C197934379 @default.
• W2922369568 hasConcept C2777658100 @default.
• W2922369568 hasConcept C2777701055 @default.
• W2922369568 hasConcept C2778715236 @default.
• W2922369568 hasConcept C2778822529 @default.
• W2922369568 hasConcept C2779134260 @default.
• W2922369568 hasConcept C502942594 @default.
• W2922369568 hasConcept C71924100 @default.
• W2922369568 hasConcept C82210918 @default.

• next